Jazz Pharmaceuticals plc

JAZZNASDAQHealthcare● Active

$238.57

$-1.49(-0.62%)

Market Cap$15.0B

P/E Ratio—

52W High$243.32

52W Low$105

Avg Volume916K

Open$241.95

Beta0.33

Net Income Financials Revenue

Jazz Pharmaceuticals plc (JAZZ) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

JAZZ · net income · updated Jun 8, 2026

Core profitability metrics

JAZZ · net income · margin · TTM · CAGR

Net income was −$356.1M for FY2025 (fiscal year ending 2025-12-31), down 163.6% year-over-year. Net profit margin was -8.3%. Based on available data, Jazz Pharmaceuticals plc has been profitable since at least 2011.

FY2025 Net Income−$356.1M▼ -163.6% YoY

Trailing 12M (TTM)$29.5Mtrailing 4 quarters sum

Net Profit Margin-8.3%−$356.1M ÷ $4.27B

YoY Change-163.6%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · JAZZ net income history · JAZZ profit margin

Annual net income data

JAZZ · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$356.1M▼ 163.6%-8.3%$4.27B

FY2024$560.1M▲ +35.0%13.8%$4.07B

FY2023$414.8M▲ +285.1%10.8%$3.83B

FY2022Loss−$224.1M▲ +31.9%-6.1%$3.66B

FY2021Loss−$329.0M▼ 237.9%-10.6%$3.09B

Net income vs peers (Healthcare)

JAZZ vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Jazz Pharmaceuticals plcYOU

JAZZ

−$356.1M-163.6%-8.3%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Jazz Pharmaceuticals plc (JAZZ) reported net income of −$356.1M for FY2025 (fiscal year ending 2025-12-31), down 163.6% year-over-year. The net profit margin was -8.3% — meaning the company kept $-0.08 of every dollar of revenue as profit.

Based on available data, Jazz Pharmaceuticals plc has been profitable since at least 2011. Net income reached a peak of $560.1M in FY2024. Data available for 15 fiscal years.

Jazz Pharmaceuticals plc's net profit margin was -8.3% for FY2025, based on the latest annual results.

Investors sometimes search for "Jazz Pharmaceuticals plc net worth" — the company's market capitalization is a separate figure from JAZZ net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

JAZZ net income · 5 questions

Jazz Pharmaceuticals plc is not currently profitable on an annual basis. The company reported a net loss of $356.1M for FY2025.

is JAZZ profitabledoes JAZZ make a profitJAZZ profitabilityJAZZ profitable company

▸ Source: FMP /income-statement · GAAP · Jazz Pharmaceuticals plc · Jazz Pharmaceuticals plc SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026